Trade PBH stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Prestige Consumer Healthcare Inc. (PBH) is trading at US$47.73, up 1.99% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$2.43B. Over the past 52 weeks, PBH has traded between US$42.62 and US$71.07. On Syfe you can trade PBH with $0 commission and add it to your watchlist.
| Previous close | US$46.80 |
|---|---|
| Market cap | US$2.43B |
| P/E ratio | 9.85 |
| 52-week range | US$42.62 – US$71.07 |
| Volume | 619.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Year: 2005
Prestige Consumer Healthcare Shares Rise After Fiscal Q1 Beat, Fiscal 2027 Outlook Lifted
Aug 6, 1:50 PM · MT Newswires
-- Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Reports Q1 Revenue $265.7M, vs. FactSet Est of $250.3M
Aug 6, 10:08 AM · MT Newswires
-- Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Posts Q1 Adjusted EPS $0.98 per Share, vs. FactSet Est of $0.88
Aug 6, 10:07 AM · MT Newswires
Prestige Plans $400 Million Private Offering of Senior Notes
Jun 30, 2:15 PM · MT Newswires
Prestige Consumer Healthcare Closes Acquisition of Breathe Right From Foundation Consumer Healthcare
Jun 16, 11:17 AM · MT Newswires
Prestige Consumer Healthcare Inc. (PBH) stock is trading at US$47.73, +1.99% from the previous close of US$46.80.
The market cap for Prestige Consumer Healthcare Inc. (PBH) stock is approximately US$2.43B.
The price-to-earnings ratio for Prestige Consumer Healthcare Inc. (PBH) is 9.85, based on the latest reported earnings.
The 52-week high for Prestige Consumer Healthcare Inc. (PBH) stock is US$71.07.
The 52-week low for Prestige Consumer Healthcare Inc. (PBH) stock is US$42.62.
Prestige Consumer Healthcare Inc. (PBH) does not currently pay a dividend.
Stay on top of PBH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
